Reliably manufacturing consistent LNPs was another challenge, and producing the raw materials needed to make the particles is a limiting factor in the production of COVID-19 vaccines today.

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world. Aided by expedited ...

Scientists demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to ...

Cambridge, Massachusetts-based Alnylam sued Pfizer and BioNTech in 2022, alleging their COVID-19 vaccines infringed patents ...

A team led by scientists at the University of Nottingham's School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the ...

A mass spec-based method for analyzing the structure of lipid nanoparticles could yield new insights that improve vaccine and ...

A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...

Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine and drug delivery ...